207 related articles for article (PubMed ID: 23649590)
1. Assessment of exocrine pancreatic function by secretin-stimulated magnetic resonance cholangiopancreaticography and diffusion-weighted imaging in healthy controls.
Wathle GK; Tjora E; Ersland L; Dimcevski G; Salvesen ØO; Molven A; Njølstad PR; Haldorsen IS
J Magn Reson Imaging; 2014 Feb; 39(2):448-54. PubMed ID: 23649590
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of chronic pancreatitis by using apparent diffusion coefficient measurements at 3.0-T MR following secretin stimulation.
Akisik MF; Sandrasegaran K; Jennings SG; Aisen AM; Lin C; Sherman S; Rydberg MP
Radiology; 2009 Aug; 252(2):418-25. PubMed ID: 19508986
[TBL] [Abstract][Full Text] [Related]
3. Exocrine pancreatic function assessed by secretin cholangio-Wirsung magnetic resonance imaging.
Calculli L; Pezzilli R; Fiscaletti M; Casadei R; Brindisi C; Gavelli G
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):192-5. PubMed ID: 18397857
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI of the pancreas: correlation with secretin endoscopic pancreatic function test (ePFT).
Balci NC; Momtahen AJ; Akduman EI; Alkaade S; Bilgin M; Burton FR
Acad Radiol; 2008 Oct; 15(10):1264-8. PubMed ID: 18790398
[TBL] [Abstract][Full Text] [Related]
5. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the stimulating effect of a low dose of secretin compared to the standard dose on the exocrine pancreas with MRCP: preliminary results in normal subjects (MRCP quantification of secretin stimulation).
Bali MA; Sontou R; Arvanitakis M; Metens T; Devière J; Matos C
Abdom Imaging; 2007 Nov; 32(6):743-8. PubMed ID: 17253108
[TBL] [Abstract][Full Text] [Related]
7. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
8. Secretin-stimulated MRCP in volunteers: assessment of safety, duct visualization, and pancreatic exocrine function.
Mensel B; Messner P; Mayerle J; Fluhr G; Völzke H; Lerch MM; Ittermann T; Kühn JP
AJR Am J Roentgenol; 2014 Jan; 202(1):102-8. PubMed ID: 24370134
[TBL] [Abstract][Full Text] [Related]
9. Secretin-Enhanced Magnetic Resonance Cholangiopancreatography for Assessing Pancreatic Secretory Function in Children.
Trout AT; Wallihan DB; Serai S; Abu-El-Haija M
J Pediatr; 2017 Sep; 188():186-191. PubMed ID: 28693787
[TBL] [Abstract][Full Text] [Related]
10. Suspected chronic pancreatitis with normal MRCP: findings on MRI in correlation with secretin MRCP.
Balci NC; Alkaade S; Magas L; Momtahen AJ; Burton FR
J Magn Reson Imaging; 2008 Jan; 27(1):125-31. PubMed ID: 18058927
[TBL] [Abstract][Full Text] [Related]
11. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement.
Akisik MF; Aisen AM; Sandrasegaran K; Jennings SG; Lin C; Sherman S; Lin JA; Rydberg M
Radiology; 2009 Jan; 250(1):103-9. PubMed ID: 19001148
[TBL] [Abstract][Full Text] [Related]
12. Exocrine pancreatic function in hepatocyte nuclear factor 1β-maturity-onset diabetes of the young (HNF1B-MODY) is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas.
Tjora E; Wathle G; Erchinger F; Engjom T; Molven A; Aksnes L; Haldorsen IS; Dimcevski G; Raeder H; Njølstad PR
Diabet Med; 2013 Aug; 30(8):946-55. PubMed ID: 23600988
[TBL] [Abstract][Full Text] [Related]
13. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.
Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C
Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868
[TBL] [Abstract][Full Text] [Related]
14. Secretin-enhanced MRCP: review of technique and application with proposal for quantification of exocrine function.
Sanyal R; Stevens T; Novak E; Veniero JC
AJR Am J Roentgenol; 2012 Jan; 198(1):124-32. PubMed ID: 22194487
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MR imaging in the evaluation of pancreatic exocrine function before and after secretin stimulation.
Erturk SM; Ichikawa T; Motosugi U; Sou H; Araki T
Am J Gastroenterol; 2006 Jan; 101(1):133-6. PubMed ID: 16405545
[TBL] [Abstract][Full Text] [Related]
16. MRI assessment of chronic pancreatitis.
Balcı C
Diagn Interv Radiol; 2011 Sep; 17(3):249-54. PubMed ID: 20945291
[TBL] [Abstract][Full Text] [Related]
17. MRI and S-MRCP findings in patients with suspected chronic pancreatitis: correlation with endoscopic pancreatic function testing (ePFT).
Balci NC; Smith A; Momtahen AJ; Alkaade S; Fattahi R; Tariq S; Burton F
J Magn Reson Imaging; 2010 Mar; 31(3):601-6. PubMed ID: 20187202
[TBL] [Abstract][Full Text] [Related]
18. The effect of prior sphincterotomy on the secretin-stimulated magnetic resonance cholangiopancreatography (s-MRCP).
Chopra A; Alkaade S; Balci NC; Burton F
Acad Radiol; 2009 Nov; 16(11):1381-5. PubMed ID: 19683944
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of somatostatin inhibitory effect on pancreatic exocrine function using secretin-enhanced dynamic magnetic resonance cholangiopancreatography: a crossover, randomized, double blind, placebo-controlled study.
Bali MA; Golstein P; Devière J; Chatterjee N; Matos C
Pancreas; 2006 May; 32(4):346-50. PubMed ID: 16670616
[TBL] [Abstract][Full Text] [Related]
20. Normal pancreatic exocrine function does not exclude MRI/MRCP chronic pancreatitis findings.
Alkaade S; Cem Balci N; Momtahen AJ; Burton F
J Clin Gastroenterol; 2008 Sep; 42(8):950-5. PubMed ID: 18645530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
